Coverage
-
December 21, 2012
A Rhode Island federal judge ruled Wednesday that a Massachusetts statute of limitations barred a suit against Novartis Pharmaceuticals Corp. claiming the bone drug Aredia caused a woman's jaw condition, saying she refused to apply a novel tolling theory to another state's law.
1 other articles on this case.
View all »